These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21897248)

  • 1. Nanoparticle-based delivery for the treatment of inner ear disorders.
    Pyykkö I; Zou J; Zhang W; Zhang Y
    Curr Opin Otolaryngol Head Neck Surg; 2011 Oct; 19(5):388-96. PubMed ID: 21897248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.
    Pyykkö I; Zou J; Schrott-Fischer A; Glueckert R; Kinnunen P
    Methods Mol Biol; 2016; 1427():363-415. PubMed ID: 27259938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise.
    Wagner E
    Acc Chem Res; 2012 Jul; 45(7):1005-13. PubMed ID: 22191535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
    Khalil IA; Kogure K; Futaki S; Harashima H
    Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine-based amphiphilic core-shell nanoparticles: study of gene delivery and intracellular trafficking.
    Siu YS; Li L; Leung MF; Lee KL; Li P
    Biointerphases; 2012 Dec; 7(1-4):16. PubMed ID: 22589059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperbranched polysiloxysilane nanoparticles: surface charge control of nonviral gene delivery vectors and nanoprobes.
    Kim WJ; Bonoiu AC; Hayakawa T; Xia C; Kakimoto MA; Pudavar HE; Lee KS; Prasad PN
    Int J Pharm; 2009 Jul; 376(1-2):141-52. PubMed ID: 19409467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery.
    Roy S; Johnston AH; Newman TA; Glueckert R; Dudas J; Bitsche M; Corbacella E; Rieger G; Martini A; Schrott-Fischer A
    Int J Pharm; 2010 May; 390(2):214-24. PubMed ID: 20153412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular protein engineering for non-viral gene therapy.
    Arís A; Villaverde A
    Trends Biotechnol; 2004 Jul; 22(7):371-7. PubMed ID: 15245910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances.
    Rehman Zu; Zuhorn IS; Hoekstra D
    J Control Release; 2013 Feb; 166(1):46-56. PubMed ID: 23266451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.
    Maitra A
    Expert Rev Mol Diagn; 2005 Nov; 5(6):893-905. PubMed ID: 16255631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin functionalized nanocarriers for gene delivery.
    Gajbhiye V; Gong S
    Biotechnol Adv; 2013; 31(5):552-62. PubMed ID: 23347981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells.
    Glover DJ; Ng SM; Mechler A; Martin LL; Jans DA
    FASEB J; 2009 Sep; 23(9):2996-3006. PubMed ID: 19395475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer in inner ear cells: a challenging race.
    Sacheli R; Delacroix L; Vandenackerveken P; Nguyen L; Malgrange B
    Gene Ther; 2013 Mar; 20(3):237-47. PubMed ID: 22739386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro and in vivo studies on hydroxyapatite nanoparticles as a novel vector for inner ear gene therapy].
    Sun H; Jiang M; Zhu SH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 43(1):51-7. PubMed ID: 18357714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
    Kumari A; Kumar V; Yadav SK
    Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear.
    Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD
    Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.